Resources

Tim Martin, Executive VP of Product & Development at Yseop was recently featured in Forbes discussing AI regulation and the EU AI Act.
Listen to the eighth episode of AI Uncovered with Fred Schonenberg
See how Yseop Copilot is different from other Generative AI technologies across BioPharma and regulated industries.
Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.
Generative AI technologies enable the pharmaceutical industry to provide enhanced and quality content automation.
Explore the remarkable milestones and moments that shaped Yseop’s journey in life sciences in 2023.
Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.
Yseop recaps Accenture’s Technology Vision 2023 for Biopharma report.
Listen to the next episode of AI Uncovered with Sarah Tilly.
Scroll to Top